vs
都乐（DOLE）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
都乐的季度营收约是瑞思迈的1.6倍（$2.3B vs $1.4B），瑞思迈净利率更高（27.6% vs 0.2%，领先27.4%），瑞思迈同比增速更快（11.0% vs 10.5%），过去两年瑞思迈的营收复合增速更高（7.9% vs 3.2%）
都乐 plc 是一家爱尔兰裔美国农业跨国企业，总部位于爱尔兰都柏林，是全球规模领先的果蔬生产商之一。公司拥有3.85万名全职及季节性员工，在75个国家供应约300种产品，2021年营收达65亿美元。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
DOLE vs RMD — 直观对比
营收规模更大
DOLE
是对方的1.6倍
$1.4B
营收增速更快
RMD
高出0.5%
10.5%
净利率更高
RMD
高出27.4%
0.2%
两年增速更快
RMD
近两年复合增速
3.2%
损益表 — Q3 FY2025 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.3B | $1.4B |
| 净利润 | $5.1M | $392.6M |
| 毛利率 | 6.8% | 61.8% |
| 营业利润率 | 1.1% | 34.6% |
| 净利率 | 0.2% | 27.6% |
| 营收同比 | 10.5% | 11.0% |
| 净利润同比 | -64.6% | 13.9% |
| 每股收益（稀释后） | $0.05 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOLERMD
| Q2 26 | — | $1.4B | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | $2.3B | $1.3B | ||
| Q2 25 | $2.4B | $1.3B | ||
| Q1 25 | $2.1B | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | $2.1B | $1.2B | ||
| Q2 24 | $2.1B | $1.2B |
净利润DOLERMD
| Q2 26 | — | $392.6M | ||
| Q4 25 | — | $392.6M | ||
| Q3 25 | $5.1M | $348.5M | ||
| Q2 25 | $10.0M | $379.7M | ||
| Q1 25 | $38.9M | $365.0M | ||
| Q4 24 | — | $344.6M | ||
| Q3 24 | $14.4M | $311.4M | ||
| Q2 24 | $80.1M | $292.2M |
毛利率DOLERMD
| Q2 26 | — | 61.8% | ||
| Q4 25 | — | 61.8% | ||
| Q3 25 | 6.8% | 61.5% | ||
| Q2 25 | 9.0% | 60.8% | ||
| Q1 25 | 8.7% | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | 8.0% | 58.6% | ||
| Q2 24 | 9.4% | 58.5% |
营业利润率DOLERMD
| Q2 26 | — | 34.6% | ||
| Q4 25 | — | 34.6% | ||
| Q3 25 | 1.1% | 33.4% | ||
| Q2 25 | 4.3% | 33.7% | ||
| Q1 25 | 3.2% | 33.0% | ||
| Q4 24 | — | 32.5% | ||
| Q3 24 | 2.3% | 31.6% | ||
| Q2 24 | 4.0% | 31.2% |
净利率DOLERMD
| Q2 26 | — | 27.6% | ||
| Q4 25 | — | 27.6% | ||
| Q3 25 | 0.2% | 26.1% | ||
| Q2 25 | 0.4% | 28.2% | ||
| Q1 25 | 1.9% | 28.3% | ||
| Q4 24 | — | 26.9% | ||
| Q3 24 | 0.7% | 25.4% | ||
| Q2 24 | 3.8% | 23.9% |
每股收益（稀释后）DOLERMD
| Q2 26 | — | $2.68 | ||
| Q4 25 | — | $2.68 | ||
| Q3 25 | $0.05 | $2.37 | ||
| Q2 25 | $0.10 | $2.58 | ||
| Q1 25 | $0.41 | $2.48 | ||
| Q4 24 | — | $2.34 | ||
| Q3 24 | $0.15 | $2.11 | ||
| Q2 24 | $0.84 | $1.97 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $321.0M | $1.4B |
| 总债务越低越好 | — | $663.8M |
| 股东权益账面价值 | $1.4B | $6.3B |
| 总资产 | $4.5B | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资DOLERMD
| Q2 26 | — | $1.4B | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | $321.0M | $1.4B | ||
| Q2 25 | $323.1M | $1.2B | ||
| Q1 25 | $261.0M | $932.7M | ||
| Q4 24 | — | $521.9M | ||
| Q3 24 | $266.4M | $426.4M | ||
| Q2 24 | $225.8M | $238.4M |
总债务DOLERMD
| Q2 26 | — | $663.8M | ||
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M | ||
| Q2 24 | — | $697.3M |
股东权益DOLERMD
| Q2 26 | — | $6.3B | ||
| Q4 25 | — | $6.3B | ||
| Q3 25 | $1.4B | $6.1B | ||
| Q2 25 | $1.4B | $6.0B | ||
| Q1 25 | $1.3B | $5.5B | ||
| Q4 24 | — | $5.3B | ||
| Q3 24 | $1.4B | $5.2B | ||
| Q2 24 | $1.4B | $4.9B |
总资产DOLERMD
| Q2 26 | — | $8.5B | ||
| Q4 25 | — | $8.5B | ||
| Q3 25 | $4.5B | $8.3B | ||
| Q2 25 | $4.7B | $8.2B | ||
| Q1 25 | $4.5B | $7.6B | ||
| Q4 24 | — | $7.1B | ||
| Q3 24 | $4.5B | $7.2B | ||
| Q2 24 | $4.4B | $6.9B |
负债/权益比DOLERMD
| Q2 26 | — | 0.11× | ||
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $87.4M | — |
| 自由现金流经营现金流 - 资本支出 | $66.5M | — |
| 自由现金流率自由现金流/营收 | 2.9% | — |
| 资本支出强度资本支出/营收 | 0.9% | — |
| 现金转化率经营现金流/净利润 | 17.12× | — |
| 过去12个月自由现金流最近4个季度 | $13.7M | — |
8季度趋势，按日历期对齐
经营现金流DOLERMD
| Q2 26 | — | — | ||
| Q4 25 | — | $339.7M | ||
| Q3 25 | $87.4M | $457.3M | ||
| Q2 25 | $18.3M | $538.8M | ||
| Q1 25 | $-78.8M | $578.7M | ||
| Q4 24 | — | $308.6M | ||
| Q3 24 | $101.0M | $325.5M | ||
| Q2 24 | $40.2M | $440.1M |
自由现金流DOLERMD
| Q2 26 | — | — | ||
| Q4 25 | — | $311.2M | ||
| Q3 25 | $66.5M | $414.4M | ||
| Q2 25 | $-1.0M | $508.2M | ||
| Q1 25 | $-131.6M | $557.9M | ||
| Q4 24 | — | $288.0M | ||
| Q3 24 | $79.9M | $307.7M | ||
| Q2 24 | $22.8M | $415.2M |
自由现金流率DOLERMD
| Q2 26 | — | — | ||
| Q4 25 | — | 21.9% | ||
| Q3 25 | 2.9% | 31.0% | ||
| Q2 25 | -0.0% | 37.7% | ||
| Q1 25 | -6.3% | 43.2% | ||
| Q4 24 | — | 22.5% | ||
| Q3 24 | 3.9% | 25.1% | ||
| Q2 24 | 1.1% | 33.9% |
资本支出强度DOLERMD
| Q2 26 | — | — | ||
| Q4 25 | — | 2.0% | ||
| Q3 25 | 0.9% | 3.2% | ||
| Q2 25 | 0.8% | 2.3% | ||
| Q1 25 | 2.5% | 1.6% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | 1.0% | 1.5% | ||
| Q2 24 | 0.8% | 2.0% |
现金转化率DOLERMD
| Q2 26 | — | — | ||
| Q4 25 | — | 0.87× | ||
| Q3 25 | 17.12× | 1.31× | ||
| Q2 25 | 1.84× | 1.42× | ||
| Q1 25 | -2.02× | 1.59× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | 7.01× | 1.05× | ||
| Q2 24 | 0.50× | 1.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
